Uses

Antineoplastic agent used with prednisone for metastatic castration-resistant prostate cancer previously treated with a docetaxel-containing regimen.

Do not use if

Neutrophil count ≤1500/mm³, severe hypersensitivity to cabazitaxel or polysorbate 80, and severe hepatic impairment.

Common adverse effects include neutropenia, anemia, diarrhea, fatigue, infections, nausea, and vomiting.

Serious neutropenia and hypersensitivity reactions may occur. Frequent blood count monitoring is required.

Microtubule inhibitor that binds tubulin, stabilizes microtubules, and inhibits cellular division.

Store at approximately 25°C. Do not refrigerate and handle as a hazardous cytotoxic medicine.